The Law Offices of Vincent Wong Announces an Investigation into the Possible Breaches of Fiduciary Duty by the Board of ZymoG...
08 Septiembre 2010 - 11:41AM
Business Wire
The Law Offices of Vincent Wong is investigating the Board of
Directors of ZymoGenetics, Inc. (NasdaqGM: ZGEN) for possible
breaches of fiduciary duty and other violations of state law in
connection with their attempt to sell the Company to Bristol-Myers
Squibb Co. ("Bristol-Myers Squibb") (NYSE: BMY). Under the terms of
the proposed transaction, ZymoGenetics shareholders will receive
$9.75 in cash for each share of ZymoGenetics common stock they own
for a total transaction value of approximately $885 million.
The investigation concerns whether the ZymoGenetics Board of
Directors breached their fiduciary duties to ZymoGenetics
stockholders by failing to adequately shop the Company before
entering into this transaction and whether Bristol-Meyers Squibb is
underpaying for ZymoGenetics shares.
If you own common stock in ZymoGenetics and wish to obtain
additional information, contact Vincent Wong, Esq. either via email
vw@wongesq.com, by telephone at 212.584.2740, or visit
http://www.wongesq.com/zymogenetics-zgen.html.
Vincent Wong, Esq. is an experienced attorney that has
represented investors in securities litigations involving financial
fraud and violations of shareholder rights.
Generation Z ETF (NASDAQ:ZGEN)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Generation Z ETF (NASDAQ:ZGEN)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Generation Z ETF (NASDAQ): 0 recent articles
Más de The Law Offices of Vincent Wong Artículos de Noticias